期刊文献+

耐氨基糖苷类铜绿假单胞菌相关耐药基因的研究 被引量:5

Researches on the correlated resistant genes of aminoglycosides-resistant Pseudomonas aerugionsa
下载PDF
导出
摘要 目的了解广州地区耐氨基糖苷类抗生素铜绿假单胞菌的氨基糖苷类修饰酶(AMEs)基因和甲酰化酶基因的存在情况。方法用聚合酶链反应(PCR)测定临床分离的196株氨基糖苷类抗生素耐药的铜绿假单胞菌7种主要的AMEs基因和2种甲酰化酶基因。结果广州地区铜绿假单胞菌的AMEs基因携带率较高(93.37%),其修饰酶基因检出率分别为ant(3")-I(54.59%),aac(3)-II(44.89%),aac(6')-II(43.37%),aac(6')-I(36.73%),ant(2")-I(32.14%),aph(3')-IV(19.90%),aac(3)-I(0);同时携带2种或2种以上AMEs基因的菌株占70.92%;未检测到甲酰化酶基因阳性的菌株。结论广州地区铜绿假单胞菌中AMEs基因携带率较高,已出现多型别流行趋势,同一菌株携带多个不同的AMEs基因现象较多;尚未发现有甲酰化酶的流行。 Objective To investigate the existing situation of aminoglycoside modifying enzyme (AMEs) gene and methylation gene of aminoglycoside-resitant Pseudomonas aeruginosa in Guangzhou area. Methods 196 strains of aminoglycoside-resitant P. aeruginosa isolated in Guangzhou were detected f0r 7 main kinds of AMEs gene and 2 kinds of methylation genes by polymerase chain reaction(PCR). Results Of the aminoglycoside -resitant P aeruginosa isolated in Guangzhou, 93.37% isolates were positive with the primers specific for AMEs. The detection rates of these genotypes were: ant(3")-I (54.59%), aac(3)-II (44.89%), aac(6')-II (43.37%), aac(6')-I (36.73%), ant(2")-I (32.14%), aph(3')-IV (19.90%), aac(3)-I (0). The isolates rate that simultaneously carrying two or more genetypes was 70.92%, and the methylation genes were not detected in any of file aminoglycoside-resitant P aeruginosa isolated. Conclusion The P. aeruginosa isolated in Guangzhou that cadging the AMEs has a high level, and the genetype is multiple. Besides, there is no prevalence with methylation in Guangzhou at present. The phenomenon that carrying multiple genetypes in one isolates is quite a lot.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2012年第7期501-506,共6页 Chinese Journal of Antibiotics
基金 国家重大传染病防治科技重大专项(No.2009ZX10004-213)
关键词 铜绿假单胞菌 氨基糖苷类修饰酶 甲酰化酶 基因型 耐药 P aeruginosa Aminoglycoside modifying enzyme gene Methylation genes Genotype Drug resistance
  • 相关文献

参考文献9

  • 1Kayabas U, Bayraktar M, Otlu B, et al. An outbreak of Pseudomonas aeruginosa because of inadequate disinfection procedures in a urology unit: a pulsed-field gel electrophoresis-based epidemiologic study[J]. Am .1 Infect Control, 2008, 36(1): 33-38.
  • 2陈茶,黄彬,蓝锴,庞雪云,糜祖煌.铜绿假单胞菌“泛耐株”耐药相关基因研究[J].中国抗生素杂志,2009,34(2):111-113. 被引量:26
  • 3Doi Y, de Oliveira Garcia D, Adams J, et al. Coproduction of novel 16S rRNA methylase RmtD and metallo-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil[J]. Antimicrob Agents Chemother, 2007,12(4): 852-856.
  • 4糜祖煌,陆亚华.氨基糖苷类修饰酶及其基因检测[J].现代实用医学,2004,16(1):13-14. 被引量:143
  • 5Yamane K, Doi Y, Yokoyama K, et al. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates[J], Antimicrob Agents Chemother, 2004, 38(2) 2069-2074.
  • 6Shaw K J, Hare R S, Sabatelli F J, et al. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinicalisolates[J]. Antimicrob Agents Chemother, 1991, 35(3): 2253-2256.
  • 7Miller G H, Sabatelli F J, Hare R S, et al. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area[J]. Clin Infect Dis, 1997, 24(Suppl 1): $46- $51.
  • 8Wachino J, Yamane K, Shibayama K, et al. Novel plasmid- mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides[J]. Antimicrob Agents Chemother, 2006, 50(1): 178-184.
  • 9Gonzalez-Zorn B, Teshager T, Casas M, et al. ArmA and aminoglycoside resistance in Escherichia coli[J]. Emerg Infect Dis, 2005, 11(6): 954-956.

二级参考文献14

  • 1陈民钧.美国临床实验室标准化研究所2005年版有关药敏试验标准化更新要点[J].中华检验医学杂志,2005,28(4):449-451. 被引量:60
  • 2倪语星.泛耐药细菌[J].辽宁医学杂志,2005,19(6):281-283. 被引量:8
  • 3陈瑞,唐英春,朱家馨,李建国.耐亚胺培南铜绿假单胞菌外膜蛋白D基因突变检测[J].中华传染病杂志,2006,24(2):80-83. 被引量:7
  • 4NCCLS. Performance standards for antimicrobial susceptibility testings[S]. Sixteenth informational supplement. NCCLS M100- S16. 2006,26(3): 38 - 39.
  • 5Marchandin H, Jean-Pierre H, De Champs C, et al. Prodution of a TEM-24 plasmid-mediated extended-spectrum β-1actamase by a clinical isolate of Pseudomonas aeruginosa[J]. Antimicrob Agents Chernother, 2000,44 ( 1 ) : 213 - 216.
  • 6Yan J J, Hsueh P R, Ko W C, et al. Metallo β-1actamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme[J]. Antimicrob Agents Chemother, 2001, 45(7): 2224 - 2228.
  • 7Aubert D, Girlich D, Naas T, et al. Functional and structural characterization of the genetic environment of all extend- ed-spectrum β-lactamase blawB gene from a Pseudomonas aeruginosa isolate obtained in India[J]. Antimicrob Agents Chemother, 2004, 48(9): 3284 -3290.
  • 8Laurent P, Laura B, Nicolas F, et al. Integron-encoded GES-type extended-spectrum β-lactamase with increased activity toward Aztreonam in Pseudomonas aeruginosa [ J ] . Antimicrob Agents Chemother, 2005, 49(8): 3593-3597.
  • 9陈代杰.抗菌生物与细菌耐药性[M].上海:华东理工大学出版社,2001.90-111.
  • 10王伟,陈瑛,钱芳,毛剑峰,薛武进.铜绿假单胞菌-内酰胺类药物耐药相关基因(18种)研究[J].中国抗生素杂志,2008,33(1):58-60. 被引量:6

共引文献167

同被引文献43

  • 1李玉红,邹全明.氨基糖苷类钝化酶耐药机制的研究进展[J].国外医学(药学分册),2005,32(3):199-203. 被引量:29
  • 2韩立中,蒋晓飞,王大方,蒋燕群,周敏,朱月秋,倪语星.一株铜绿假单胞菌中检出两种新的整合子[J].中华微生物学和免疫学杂志,2005,25(6):485-489. 被引量:15
  • 3诸葛青云,张霖,糜祖煌,仵蕾,吴晶,单浩,陈榆,黄支密.多重耐药铜绿假单胞菌氨基糖苷类修饰酶基因检测[J].温州医学院学报,2005,35(6):457-460. 被引量:3
  • 4蔡培泉,王春新,糜祖煌.铜绿假单胞菌氨基糖苷类耐药性及其修饰酶基因的研究[J].中华微生物学和免疫学杂志,2006,26(4):374-374. 被引量:9
  • 5顾兵,童明庆,赵文君,倪芳,魏源华.绿脓假单胞菌多重耐药机制的研究[J].中华检验医学杂志,2006,29(12):1097-1102. 被引量:40
  • 6Giske CG,Buar L,Sundsfjord A,et al.Alterations of porin,pumps,and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa[J].Microbial Drug Resistance,2008,14(1):23-30.
  • 7Master RN,Clark RB,Karlowsky JA,et al.Analysis of resistance,cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009[J].Int J Antimicrob Agents,2011,38(4):291-295.
  • 8Lee K,Kim MN,Kim JS,et al.Further increases in carbapenem-,amikacin-,and fluoroquinolone-resistant isolates of Acinetobacter spp.and P.aeruginosa in Korea:KONSAR study 2009[J].Yonsei Med J,2011,52(5):793-802.
  • 9Futrega K, King M, Lott WB, e! al. Treating tile whole not the hole: necessary coupling of technologies for diabetic foot ulcer treahnent [J].Trends Mol Med, 2014, 20(3): 137-142. dui: lO. lOl6/j.mol- reed.2013.12.004.
  • 10Ramakant P, Verma AK, Misra R. el al. Changing microbiological profile of palhogtmic bacteria in diabetie foot infections: lime l~r a rethink on which empirical therapy to choose[J]?Diabelologia, 201 I, 54(1): 58-64. doi: 10.1007/s00125-010-1893-7.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部